Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Income from Continuing Operations (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Income from Continuing Operations for 15 consecutive years, with 1910047.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Income from Continuing Operations rose 20.63% year-over-year to 1910047.0, compared with a TTM value of 9043565.0 through Mar 2025, up 25.81%, and an annual FY2025 reading of 13702431.0, down 12.24% over the prior year.
  • Income from Continuing Operations was 1910047.0 for Q1 2025 at Aethlon Medical, down from 1753983.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1753983.0 in Q4 2024 and bottomed at 3785698.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 2694639.59, with a median of 2571440.0 recorded in 2024.
  • The sharpest move saw Income from Continuing Operations plummeted 82.54% in 2022, then surged 49.4% in 2024.
  • Year by year, Income from Continuing Operations stood at 2527946.0 in 2021, then fell by 12.73% to 2849753.0 in 2022, then fell by 21.63% to 3466121.0 in 2023, then surged by 49.4% to 1753983.0 in 2024, then dropped by 8.9% to 1910047.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for AEMD at 1910047.0 in Q1 2025, 1753983.0 in Q4 2024, and 2808095.0 in Q3 2024.